R. Buirma

发表

Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia

J. Kastelein, B. Hutten, J. Defesche, 2003, Journal of internal medicine.

Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.

M. Castro Cabezas, A. van Tol, P. D. De Jaegere, 2005, Atherosclerosis.

Elevated Remnant-Like Particles in Heterozygous Familial Hypercholesterolemia and Response to Statin Therapy

J. Kastelein, G. Dallinga-Thie, B. Hutten, 2002, Circulation.

Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia. The examination of probands and relatives in Statin studies with familial hypercholesterolemia (ExPRESS FH).

J. Kastelein, B. Hutten, P. R. W. de Sauvage Nolting, 2002, Atherosclerosis.

UvA-DARE ( Digital Academic Repository ) Dyslipidemia ; diagnosis and treatment

M. Trip, J. Kastelein, J. Kragten, 2007 .

Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).

J. Kastelein, B. Hutten, P. R. W. de Sauvage Nolting, 2002, The American journal of cardiology.

Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study.

J. Wagenvoort, R. Buirma, A. Horrevorts, 1991, Scandinavian journal of infectious diseases. Supplementum.

Regressionn of carotid and femoral intima-media thicknesss in familial hypercholesterolemia

J. Kastelein, R. Buirma, 2007 .

Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.

A. Zwinderman, J. Kastelein, M. Trip, 2003, Archives of internal medicine.

A comparison of the efficacy and tolerability of titrate-to-goal regimens of simvastatin and fluvastatin: a randomized, double-blind study in adult patients at moderate to high risk for cardiovascular disease.

M. Trip, J. Kastelein, F. D. den Hartog, 2001, Clinical therapeutics.

Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.

A. Zwinderman, J. Kastelein, M. Trip, 2003, Archives of internal medicine.